Page last updated: 2024-10-21

3-methoxytyramine and Substance Withdrawal Syndrome

3-methoxytyramine has been researched along with Substance Withdrawal Syndrome in 2 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karoum, F1
Egan, MF1
Wyatt, RJ1
Ahtee, L1
Attila, LM1
Carlson, KR1
Haikala, H1

Other Studies

2 other studies available for 3-methoxytyramine and Substance Withdrawal Syndrome

ArticleYear
Selective reduction in dopamine turnover in the rat frontal cortex and hypothalamus during withdrawal from repeated cocaine exposure.
    European journal of pharmacology, 1994, Mar-11, Volume: 254, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Hypothalamus; Male; Prefrontal Cortex; R

1994
Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 249, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Biogenic Amines; Brain; Dopamine; Hyd

1989